Found: 12
Select item for more details and to access through your institution.
A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 10, p. 1, doi. 10.15252/emmm.202215821
- By:
- Publication type:
- Article
In Vivo Clearance of Hepatitis C Virus Nonstructural 3/4A-Expressing Hepatocytes by DNA Vaccine-Primed Cytotoxic T Lymphocytes.
- Published in:
- Journal of Infectious Diseases, 2005, v. 192, n. 12, p. 2112, doi. 10.1086/498218
- By:
- Publication type:
- Article
Functional differences in hepatitis C virus nonstructural (NS) 3/4A- and 5A-specific T cell responses.
- Published in:
- Scientific Reports, 2016, p. 24991, doi. 10.1038/srep24991
- By:
- Publication type:
- Article
A heterologous prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus.
- Published in:
- 2013
- By:
- Publication type:
- journal article
A Heterologous Prime/Boost Vaccination Strategy Enhances the Immunogenicity of Therapeutic Vaccines for Hepatitis C Virus.
- Published in:
- Journal of Infectious Diseases, 2013, v. 208, n. 6, p. 1008, doi. 10.1093/infdis/jit267
- By:
- Publication type:
- Article
Improving on the Ability of Endogenous Hepatitis B Core Antigen to Prime Cytotoxic T Lymphocytes.
- Published in:
- Journal of Infectious Diseases, 2010, v. 201, n. 12, p. 1867, doi. 10.1086/652808
- By:
- Publication type:
- Article
Functional Aspects of Intrahepatic Hepatitis B Virus-specific T Cells Induced by Therapeutic DNA Vaccination.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 3, p. 578, doi. 10.1038/mt.2014.233
- By:
- Publication type:
- Article
Therapeutic DNA Vaccination Using In Vivo Electroporation Followed by Standard of Care Therapy in Patients With Genotype 1 Chronic Hepatitis C.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 9, p. 1796, doi. 10.1038/mt.2013.119
- By:
- Publication type:
- Article
Electroporation for therapeutic DNA vaccination in patients.
- Published in:
- Medical Microbiology & Immunology, 2015, v. 204, n. 1, p. 131, doi. 10.1007/s00430-014-0384-8
- By:
- Publication type:
- Article
SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation.
- Published in:
- Clinical & Translational Immunology, 2021, v. 10, n. 7, p. 1, doi. 10.1002/cti2.1306
- By:
- Publication type:
- Article
Editorial: HBV—the naked truth?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 8, p. 963, doi. 10.1111/apt.15428
- By:
- Publication type:
- Article
Blocking Entry of Hepatitis B and D Viruses to Hepatocytes as a Novel Immunotherapy for Treating Chronic Infections.
- Published in:
- 2021
- By:
- Publication type:
- journal article